Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062538) titled 'Development and validation of a classification model for postprandial blood glucose elevation patterns' on Aug. 10.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Kewpie Corporation
Condition:
Condition - Healthy Adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To develop and validate a model for predicting postprandial blood glucose elevation patterns.
Basic objectives2 - Others
Intervention:
Interventions/Control_1 - To measure the blood glucose levels and pulse waves before and after lunch.
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - (1) Health male and female employees of the Kewpie Group
(2) Aged from 20 to 64 years at the time of providing informed consent
(3) Willing to disclose the results of their regular health checkups
(4) Provided voluntary written informed consent after receiving a full explanation of the study
Key exclusion criteria - (1) Presence of severe medical conditions or psychiatric disorders
(2) Pregnant or lactating women
(3) History of vasovagal reflex during past blood collection or needle puncture
(4) Severe skin diseases or wounds at the planned puncture site
(5) Deemed unsuitable for participation by the principal investigator
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 08 Month 06 Day
Date of IRB - 2026 Year 08 Month 06 Day
Anticipated trial start date - 2026 Year 08 Month 17 Day
Last follow-up date - 2026 Year 11 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071587
Disclaimer: Curated by HT Syndication.
